TWISTDX LIMITED

AL1 3SE (East of England)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£119,492

Sep 10 - Sep 11

Feasibility of using recombinase polymerase amplification for point of care diagnosis of Mycoplasma pneumoniae a major cause of community acquired pneumonia

Innovate UK award to TWISTDX LIMITED

£118,880

Jul 10 - Aug 11

Feasibility of using recombinase polymerase amplification for a Rapid Point of Care Test for Tuberculosis

Innovate UK award to TWISTDX LIMITED

£107,765

Jul 10 - Oct 11

Development of isothermal amplification method for point of care detection of classical swine fever virus african fever virus and avain influenza virus

Innovate UK award to TWISTDX LIMITED

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}